1,3,4,6-Tera- O-allyl- myo-inositol was converted into the 2,5-di- O-benzyl- and 2,5-di- O-p-methoxybenzyl ethers, and the products were deallylated to give the 2,5-di- O-benzyl (and p-methoxybenzyl) ethers of myo-inositol, which were converted into the mono- O-isopropylidene derivatives. Both the 2,5-di- O-benzyl ether and its mono- O-isopropylidene derivative were converted into the crystalline octa(2-cyanoethyl) ester of 2,5-di- O-benzyl- myo-inositol 1,3,4,6-tetrakisphosphate. (±)-1,3,4,5-Tetra- O-allyl- myo-inositol was converted into (±)-2,4-di- O-benzyl- myo-inositol which gave a separable mixture of the 1,6- and 5,6- O-isopropylidene derivatives. The 1,6- O-isopropylidene derivative was resolved via (−)- and (+)-ω-camphanates and was also converted into (±)-2,6-di- O-benzyl-1,5-di- O-p-methoxybenzyl- myo-inositol, which was resolved via the (−)-ω-camphanates. The 5,6- O-isopropylidene derivative and 1,3-di- O-allyl- myo-inositol were converted into (±)-1,3-di- O-allyl-2,6-di- O-benzyl- myo-inositol, which was resolved as the (−)-ω-camphanates. 1 d-1,3,4,5-Tetra- O-allyl- myo-inositol and the above described, relevant diaste reoisomers were converted into 1 d-2,6-di- O-benzyl- myo-inositol which gave the syrupy octabenzyl ester of 1 d-2,6-di- O-benzyl- myo-inositol 1,3,4,5-tetrakisphosphate.